The cardiovascular pharmacology of COX-2 inhibition.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2005, Pages 445-451

  Fries, Susanne ^a   Grosser, Tilo ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; HUMAN; HYPERTENSION; METABOLISM; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; MICE;

EID: 33751073326     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2005.1.445     Document Type: Article

References (0)